Showing results (131-140 of 159) with videos related to

Sort By:
Pageof 16
Biological Psychiatry|November 1, 1983
Cerebrospinal fluid probenecid studies: a reinterpretationR W Cowdry, M H Ebert, D P van Kammen, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1981
Specific norepinephrine and serotonin uptake inhibitors in man: a crossover study with pharmacokinetic, biochemical, neuroendocrine and behavioral parametersW Z Potter, H M Calil, I Extein, et al.
Life Sciences|July 5, 1982
Peptides in the cerebrospinal fluid of neuropsychiatric patients: an approach to central nervous system peptide functionR M Post, P Gold, D R Rubinow, et al.
The American Journal of Psychiatry|April 1, 1984
CSF 5-hydroxyindoleacetic acid levels in suicidal schizophrenic patientsP T Ninan, D P van Kammen, M Scheinin, et al.
Archives of General Psychiatry|February 1, 1993
The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and servicesD A Regier, W E Narrow, D S Rae, et al.
The American Journal of Psychiatry|November 1, 1988
The NIMH Depression Awareness, Recognition, and Treatment Program: structure, aims, and scientific basisD A Regier, R M Hirschfeld, F K Goodwin, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1983
The effect of lithium on the osmoregulation of arginine vasopressin secretionP W Gold, G L Robertson, R M Post, et al.
The American Journal of Psychiatry|December 1, 1980
Failure of naloxone to reduce manic symptomsG C Davis, I Extein, V I Reus, et al.
Talanta|October 31, 2008
Detection of apolipoprotein E genotypes by capillary electrophoresisE S Koay, M Zhu, T Wehr, et al.
Biological Psychiatry|December 1, 1978
Dopamine-beta-hydroxylase in the cerebrospinal fluid of psychiatric patientsP Lerner, F K Goodwin, D P van Kammen, et al.
Pageof 16